Staphylococcus aureus bacteremia (SAB) is an important infection with an incidence rate
ranging from 20 to 50 cases/100,000 population per year. Between 10% and 30% of these …

Staphylococcus aureus bacteraemia remains very difficult to treat, and a large proportion of
cases result in potentially lethal metastatic infection. Unpredictable and persistent …

Background Complications ofStaphylococcus aureusbacteremia (SAB) are often difficult to
identify. The ability to accurately predict the likelihood of these complications would impact …

Staphylococcus aureus bacteraemia is one of the most common serious bacterial infections
worldwide. In the UK alone, around 12 500 cases each year are reported, with an …

Cardiovascular management of septic shock : Critical Care Medicine Cardiovascular
management of septic shock : Critical Care Medicine SCCM Pediatric Critical Care …

The current duration of therapy in patients with Staphylococcus aureus bacteremia (SAB) is
based on differentiating complicated from uncomplicated disease. While this approach …

These evidence-based guidelines have been produced after a literature review of the
treatment and prophylaxis of methicillin-resistant Staphylococcus aureus (MRSA) infection …

Purpose: To review the epidemiology of Staphylococcus aureus bacteraemia (SAB) and
endocarditis (SAE), and discuss the short-and long-term outcome. Materials and methods: A …

Background. Staphylococcus aureus native valve infective endocarditis (SA-NVIE) is not
completely understood. The objective of this investigation was to describe the characteristics …

Abstract (See the editorial commentary by Holland and Fowler Jr, on pages 329–31.)
Background. There are concerns about reduced efficacy of vancomycin in patients with …